Aethlon Medical (NASDAQ:AEMD – Get Free Report) and SeaStar Medical (NASDAQ:ICU – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.
Institutional & Insider Ownership
2.0% of Aethlon Medical shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 1.1% of Aethlon Medical shares are owned by company insiders. Comparatively, 2.1% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Risk & Volatility
Aethlon Medical has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.13, suggesting that its stock price is 213% less volatile than the S&P 500.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Aethlon Medical | 0 | 0 | 1 | 0 | 3.00 |
| SeaStar Medical | 0 | 0 | 0 | 0 | 0.00 |
Aethlon Medical currently has a consensus target price of $7.00, indicating a potential upside of 1,110.03%. Given Aethlon Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Aethlon Medical is more favorable than SeaStar Medical.
Profitability
This table compares Aethlon Medical and SeaStar Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Aethlon Medical | N/A | -160.36% | -115.74% |
| SeaStar Medical | N/A | N/A | -627.49% |
Earnings & Valuation
This table compares Aethlon Medical and SeaStar Medical”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Aethlon Medical | $570,000.00 | 14.17 | -$12.21 million | ($2.82) | -0.21 |
| SeaStar Medical | $68,000.00 | 136.52 | -$26.23 million | ($11.63) | -0.18 |
Aethlon Medical has higher revenue and earnings than SeaStar Medical. Aethlon Medical is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.
Summary
Aethlon Medical beats SeaStar Medical on 9 of the 13 factors compared between the two stocks.
About Aethlon Medical
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
